SNL Creative and Iridia Collaborate on Medical Device Traceability

SNL Creative, a California-based additive manufacturing company, and Iridia, a pioneer in authenticity and traceability solutions, have partnered to revolutionize the medical device industry. The partnership promises to deliver unparalleled usability, safety, and efficiency in medical device manufacturing – providing enhanced patient safety and regulatory compliance. Iridia’s cutting-edge data embedding solutions will be integrated with SNL Creative’s precision 3D printing capabilities – delivering unparalleled benefits to manufacturers, healthcare providers, and patients.

The medical device industry faces several significant challenges, including counterfeiting (according to the World Health Organization, an estimated 8% of medical devices in circulation are counterfeit); device recalls (according to the FDA, 3,202 medical device recalls were expected in 2022, with Class I device recalls increasing 44% from 2003 to 2012); and patient safety (medical device issues are among the top 10 patient safety concerns, according to the ECRI Institute).

“Our partnership with Iridia represents a significant step forward in medical device manufacturing,” said Shawn Zindroski, founder and COO of SNL Creative. “By combining our expertise in precision 3D printing with Iridia’s Embedded Molecular Data technology, we are setting new standards for device authenticity and traceability.”

Iridia’s embedded molecular data technology enables cryptographic security coatings – ensuring the authenticity and integrity of medical devices by giving each device a unique, verifiable identity; metadata embedding – where patient-specific data can be embedded directly into devices via a durable coating or within device materials; and embedded traceability – enabling confirmation of origin, destination, and other important information.

SNL Creative’s expertise includes precision 3D printing of high-quality, precision medical devices and components, a wide range of materials suitable for various medical applications, and customized finishing solutions that meet specific medical standards and aesthetic requirements.

The collaboration aims to enhance patient safety by ensuring the authenticity and traceability of each medical device. Integration of patient-specific data into device materials enables tailored treatment, while robust verification methods prevent counterfeit devices from entering the supply chain. Additionally, streamlined manufacturing processes and reduced compliance costs will lead to improved workflow efficiency and profitability for manufacturers.

“The integration of our molecular identity cryptography technology with SNL Creative’s manufacturing expertise marks a new era in medical device security and reliability,” said Buck Watia, vice president of product and corporate development for Iridia. “Together, we are committed to delivering the highest quality devices to healthcare providers and patients.”

Companies can partner with SNL Creative and Iridia to produce a new line of devices, each of which can include cryptographic metadata that includes manufacturing date, batch number, quality control, and even patient information – ensuring compliance with regulatory standards and enhancing patient safety.